Stereotaxis Reports Third Quarter Financi... ( ST. LOUIS Nov. 7 2011 /- Stereotaxis ...)

Stereotaxis Reports Third Quarter Financial Results

Date:11/7/2011

ST. LOUIS, Nov. 7, 2011 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) today reported financial results for the third quarter ended September 30, 2011.

Third Quarter 2011 Financial ResultsRevenue for the third quarter was $8.5 million, down 38% from the year ago period. The decrease was primarily due to softness in Niobe® robotic system sales, resulting from market demand for a more efficient solution for complex ablation procedures and the ongoing platform transition from Niobe II to the Company's new Epoch™ platform. The Company recognized revenue on one Niobe system and $1.0 million in Odyssey™ systems in the third quarter. Recurring revenue in the quarter was $6.5 million, a 14% increase from the year-ago quarter. This growth was attributable to the larger installed base of Niobe systems and increased utilization leading to greater disposable sales and service contracts over last year, as well as favorable pricing.

The Company generated global new capital orders of $2.2 million in the third quarter, which were comprised of four upgrades to the Epoch platform from Niobe II, two Vdrive™ robotic navigation systems, and $1.6 million in orders related to Odyssey.

"Our top-line performance and system orders in the quarter, as we expected, were impacted by market demand for a more efficient solution for complex ablation procedures and the ongoing platform transition from Niobe II to Epoch," said Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis. "These factors contributed to softness in Niobe II revenue and the related impact on Odyssey installations in Niobe labs. Meanwhile, we continue to build market momentum and interest in the Epoch platform ahead of its planned launch in December. We remain encouraged by the early, positive market feedback
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Stereotaxis to Report Third Quarter 2011 Financial Results and Conduct Conference Call on November 7, 2011
2. Stereotaxis to Present at the JMP Securities Healthcare Conference on September 28, 2011
3. Stereotaxis Board of Directors Reaffirms Commercialization Plans for Epoch™ and Odyssey™ Product Platforms
4. Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011
5. Stereotaxis to Present at the Canaccord Genuity Growth Conference on August 11, 2011
6. Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™
7. Stereotaxis to Report Second Quarter 2011 Financial Results and Conduct Conference Call on August 8, 2011
8. Stereotaxis and Biosense Webster Announce New Strategic Collaboration
9. Stereotaxis Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011
10. Stereotaxis Reports First Quarter 2011 Financial Results
11. Stereotaxis Introduces New Electrophysiology Platform: Epoch™

Post Your Comments:

(Date:5/21/2013)... Calif. , May 21, 2013 RenovoRx ... prestigious 2013 TiE50 "Top Startup" Award at TiEcon 2013, ... innovation, strong management team and quality of entrepreneurial ideas. ... at the Santa Clara Convention ... highly influential list of the most enterprising startup companies ...

(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... image and impressive new product developments at the Special Libraries ... ten years of unerring focus on product literature databases and ... to mark the occasion," said founding director Nigel ... interesting developments of benefit to our clients and what better ...

(Date:5/21/2013)... , May 21, 2013 /PRNewswire-iReach/ -- The 2013 ... NJ has attracted the greatest number of "Emerging" ... President, Mark Alexay . "No ... to attend this year. The show,s still 4 months ... companies. This is a big surprise and great ...

Breaking Medicine Technology:RenovoRx Named Winner of 2013 TiE50 "Top Startup" 2 Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2 Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3 Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2

[0] RenovoRx Named Winner of 2013 TiE50 "Top Startup"[0] Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia [0] Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show

... Conn., Jan. 7 Alexion,Pharmaceuticals, Inc. (the ... commenced dosing in the AEGIS study, a ... and pharmacology of Soliris(R) (eculizumab),as a treatment ... When fully enrolled, the open-label study, authorized,by ...

... Innocoll, Inc., a privately-held,specialty pharmaceutical company, announced ... phase 2 clinical trials sponsored by its ... CollaRx(R) BUPIVACAINE SURGICAL,IMPLANT for the management of ... BUPIVACAINE SURGICAL IMPLANT is a biodegradable and ...

Cached Medicine Technology:Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 2 Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 3 Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 4 Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 5 Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 6 Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 2 Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 3 Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 4

Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain

(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and ... free Community Wellness Fair to educate the public on health ... held on Wednesday, May 22, 2013 from 4:00 pm until ... Old Mallard Creek Road, Charlotte, NC 29262). , ... the Mecklenburg County Department of Social Services are ...

(Date:5/21/2013)... AZ (PRWEB) May 21, 2013 ... and inventors who want to develop their ideas ... summer program. , The university is recruiting ... revolutionary new “formation space” that provides early-stage entrepreneurs ... While AREA48 is open to anyone, ASU is ...

(Date:5/21/2013)... 2013 Diversity Focus, a non-profit organization ... all residents in the Creative Corridor region, is releasing ... a news conference on Thursday, May 23rd at 10:30 ... in 2008. , The survey is a ... support efforts that attract, nurture and retain people of ...

(Date:5/21/2013)... two proteins, thrombospondin-1 and prosaposin, play in discouraging ... a five-amino acid fragment of prosaposin that significantly ... breast and lung cancer. The findings suggest that ... a variety of cancers. , The study ... Children,s Hospital, Vivek Mittal, PhD, at Weill Cornell ...

(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Vinci surgery robot lawsuit is nearing its conclusion ... According to Bloomberg.com, during closing statements yesterday, an attorney ... dealership, alleging the company wanted to tie sales and ... do all the training to keep control of surgeons, ...

Breaking Medicine News(10 mins):Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4 Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2 Health News:Changing cancer's environment to halt its spread 2 Health News:Changing cancer's environment to halt its spread 3 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4

[0] Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives [0] ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors [0] Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m.[0] Changing cancer's environment to halt its spread [0] Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial

... , ROCHESTER, N.Y., Aug. 12 VirtualScopics, Inc. (Nasdaq: ... announced its financial results for the quarter and six months ended June 30, ... Revenues for the second quarter of 2009 increased 47% to $2.5 ... Gross profit for the second quarter of 2009 increased 96% ...

... NEWARK, N.J., Aug. 12 BioNeutral Group, Inc. ("BioNeutral") (OTC ... that ATS Labs using the EPA required AOAC Sporicidal Test with Ygiene(TM) ... over one million live Clostridium ... time frame - performance which is up to 75 times faster than ...

... With the recent increase in the tobacco tax, many Floridians ... times - do they pay the extra dollar per pack or ... The Florida Quitline (1-877-U-CAN-NOW) is here to help by offering free ... According to Kim Berfield, Deputy Secretary of the Florida Department of ...

... , , , , ... a leading provider of Linux-bas e d ... Systems, a national health care management company, has deployed Arkeia Network Backup. ... Goold has realized dramatic improvements in backup performance and in backup administration. ...

... August 12 Fountain Healthy Aging,Inc. announced on August 12 ... Partners and Oak Resources Limited which provides the Company,with a ... the,agreement, Fountain has the right to draw down from the ... a term of 24 months. The,first tranche investment of $1,000,000 ...

... , WESTFIELD, Ind., Aug. 12 ... company for healthcare providers, announced the successful "Stage 6" designation ... hospital located in Silver City, New Mexico. maxIT assisted the ... IT consultants to support the implementation of several HIS modules. ...

VirtualScopics, Inc. Reports a Record Breaking Quarter BioNeutral's Ygiene(TM) Achieves World's Fastest Kill Time With a 100% Total Spore Eradication Verified In Independent Sporicidal/Sterilant Test The Time To Quit Is Now -- Free NRT Is Available Goold Health Systems Accelerates Backups by 5-times Using Arkeia Network Backup Fountain Healthy Aging Inc Announces $5,000,000 Equity Line Of Credit Investment Secured maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition

Custom Pediatric Nebulizer Assembly W/Tubing...

... Patients over the age of 3 can choose ... STAR®. The same design principle applies to both:, ... and minimize aerosol output when the patient exhales ... optimum size to leave the nebulizer. The result ...

... medication nebulizer achieves optimum lung penetration for ... range is 1.04-1.10 µ at 6-8 LPM. ... outlet., ,As the world leader in ... the assurance of proven technology by offering ...

... Portex® medication nebulizers offer a spill-proof design ... to a 45° angle. All medical nebulizers ... wide variety of configurations are available., ... , ,Portex® medication nebulizers feature consistently ...

Medicine Products:

Pediatric Custom Nebulizers PARI LC STAR® Reusable Nebulizer Raindrop® Medication Nebulizer - Pediatric Aerosol Mask & Tubing 007767 Medication Nebulizer Kit